QHSLab, Inc. reported its financial results for the third quarter of 2025, revealing a revenue increase of 35.4% to $737,066 compared to $544,285 in the same period last year. For the nine months ending September 30, 2025, total revenue reached $1,987,931, up from $1,505,945 in the prior year. The growth was primarily driven by a significant rise in Integrated Service Program (ISP) revenues, which surged by 122% in the third quarter and 74.9% year-to-date, reflecting the company's strategic focus on enhancing its SaaS offerings for primary care physicians.
Despite the revenue growth, QHSLab reported a net income of $33,411 for the third quarter, a decrease from $49,765 in the same quarter of 2024. The nine-month period saw a net loss of $99,156, contrasting with a profit of $28,350 in the previous year. The company attributed the decline in profitability to increased operating expenses, particularly in sales and marketing, which rose by 48.7% for the quarter and 28.1% year-to-date, as QHSLab invested in expanding its customer base and product offerings.
Operationally, QHSLab's total current assets increased to $428,599 as of September 30, 2025, compared to $420,827 at the end of 2024. However, current liabilities also rose to $2,345,536 from $2,407,308, leading to a stockholders' deficit of $610,912. The company continues to face challenges related to its debt obligations, with significant portions of its liabilities tied to convertible notes and loans, which have resulted in increased interest expenses due to defaults.
Looking ahead, QHSLab plans to further enhance its QHSLab platform and expand its product line, including additional point-of-care diagnostics and digital medicine programs. The company aims to increase its market share by onboarding more primary care physicians and leveraging its existing products to generate additional revenue streams. However, the ongoing financial challenges and the need for additional capital raise concerns about the company's ability to sustain operations without securing further financing or restructuring its existing debt.
About QHSLab, Inc.
QHSLab, Inc. develops digital healthcare software and SaaS solutions for primary care providers, focusing on chronic disease management, preventive care, and digital medicine. Its platforms, including QHSLab and AllergiEnd, enable remote monitoring, diagnostics, and targeted allergen immunotherapy, enhancing practice revenues and patient outcomes. The company operates in a highly regulated industry, competing with larger firms, and emphasizes value-based, patient-centered, and cost-effective healthcare delivery.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.